• SELECT SITE CURRENCY
Select a currency for use throughout the site
Drug-eluting Stent Market in China 2011-2015
Infiniti Research Limited, March 2012, Pages: 36
TechNavio’s analysts forecast the Drug-eluting Stent market in China to grow at a CAGR of 25.5 percent over the period 2011–2015. One of the key factors contributing to this market growth is the rising incidence of cardiovascular diseases in the country. The Drug-eluting Stent market in China has also been witnessing the trend of rise of medical tourism. However, price-cuts of Drug-eluting stents could pose a challenge to the growth of this market.
TechNavio’s report, the Drug-eluting Stent Market in China 2011–2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report focuses on China; it also covers the market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors dominating this market space include MicroPort Scientific Corp., Lepu Medical Technology Co. Ltd., Shandong JW Medical Products Co. Ltd., Abbott Vascular, and Medtronic Inc.
Key questions answered in this report:
What will the market size be in 2015 and at what rate will it grow?
What key trends is this market subject to?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the opportunities and threats faced by each of these key vendors?
What are the strengths and weaknesses of each of these key vendors?
01. Executive Summary
03. Market Coverage
04. Market Landscape
05. Rate of Incidence and Prevalence
06. Vendor Landscape
07. Buying Criteria
08. Market Growth Drivers
09. Drivers and their Impact
10. Market Challenges
11. Impact of Drivers and Challenges
12. Market Trends
13. Key Vendor Analysis
13.1 MicroPort Scientific Corp.
13.2 Lepu Medical Technology Co Ltd.
13.3 Shandong JW Medical Products Co. Ltd.
13.4 Abbott Vascular
13.5 Medtronic Inc.
14. Other Reports in this Series
List of Exhibits:
Exhibit 1: Drug-eluting Stent Market in China 2011–2015 (US$ million)
Exhibit 2: Drug-eluting Stent Market in China 2011–2015 (thousand units)
Exhibit 3: Coronary Stent Market in China by Product Segmentation 2011
Exhibit 4: Drug-eluting Stent Market in China by Vendor Segmentation 2011
TechNavio Announces the Publication of its Report – Drug-eluting Stent Market in China 2011–2015
TechNavio today launched its report Drug-eluting Stent (DES) Market in China 2011–2015 based on an in-depth study exclusively covering China. The report aims to aid decision makers’ understanding of the key trends impacting this market.
Commenting on the report, an analyst from TechNavio’s Healthcare team said, “IC procedures that are performed using DES are quite expensive. Hence, to reduce the cost of DESs to more affordable levels, the government of China and a few private players are offering reimbursements for IC procedures that are performed using DESs. However, it has been observed that stents that are imported from global healthcare vendors are either excluded from such medical insurance coverage schemes, or are only eligible for a very low percentage as reimbursement. In contrast, approximately 50–70 percent of the treatment cost is reimbursed in the case of treatments where regionally manufactured stents are used.”
According to the report, in the Healthcare sector, there are numerous litigations and intellectual property rights issues among vendors, especially medical device manufacturers. Thus, DES vendors form strategic alliances to share their core competencies, as a result of which they can help develop innovative products in an effort to avoid litigation.
Further, the report also discusses that a major challenge in the DES market in China is the fall in the prices of DESs.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key players.